IMF eyes further international expansion

Successful placement and share purchase plan to raise $41.4 million.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Litigation funder IMF (ASX: IMF) has completed the heavily oversubscribed placement of 18.5 million new shares, raising $31.4 million. This will be followed by a share purchase plan to raise another $10 million. New shares will not be entitled to the 2013 dividend. Proceeds will be applied to the redemption of any outstanding convertible notes and working capital in the international business.

To date IMF has funded 10 cases in the US through offices in Los Angeles and New York. Preparations are underway to potentially open offices in London and the Netherlands. IMF states that it sees "material opportunities" in these jurisdictions and a physical presence is required to take full advantage. In Europe IMF has commenced proceedings against various rating agencies involved in the wash-up from the GFC.

IMF is one of the world's most successful litigation funders, which just demonstrates what an infant this industry is. Generally, a litigation funder pays the legal fees and all associated costs in the undertaking of a legal action. In exchange the funder is entitled to a share of any successful settlement – in IMF's case this has averaged 34% gross and the average life of an action is 2.3 years. Of course, net proceeds are considerably less.

A litigation funder is essentially an investment manager and it follows that the key to success is the accurate selection of potentially rewarding cases to pursue and fund. Possessing astute management IMF has an outstanding record here having only lost 3% of 149 cases since listing in 2001; 65% of cases are settled before final court decisions.

IMF's current portfolio of case investments have a claim value of $1.66 billion, which should deliver a substantial and growing net profit stream over the next few years.  Management's intention is to get the portfolio to over $2 billion in the short term.

Other legally related companies on the stock exchange include lawyers Slater & Gordon (ASX: SGH) and Shine Corporate (ASX: SHJ). However legal firms in Australia cannot fund litigation proceedings and are compelled to use external parties. This convention is unlikely to change as lawyers can't be seen to have a financial interest (other than fees) in case outcomes – very confusing but that's the way it is!

Assuming all outstanding convertible notes (in practice, a good proportion will be converted into shares) are fully paid out, IMF will have cash on hand of $68.3 million and equity of $164.1 million – placing it in a strong position to take advantage of growth opportunities when they occur.

Foolish takeaway

Due to the nature of the business IMF's earnings are lumpy and dividends variable so it doesn't fit into one of the neat little boxes many investors like to see. However this presents an opportunity for the patient investor to get into a stock with genuine material upside. The intention to pursue further offshore expansion carries some risks, however management has a lengthy record of cautious progress.

In my opinion, IMF is a sound buy for investors with a medium and long term horizon; it is definitely not suitable for those seeking a regular predictable income and annual earnings certainty.

Looking to pick up a non-bank high dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Peter Andersen owns shares in IMF and Slater & Gordon

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »